Kellogg’s-Benson Hill deal aims to fix alt-meat’s sustainability issues
Benson Hill aims to scale its Ultra-High Protein soy by incorporating it into Kellogg’s MorningStar Farms alt-meat range.
Benson Hill aims to scale its Ultra-High Protein soy by incorporating it into Kellogg’s MorningStar Farms alt-meat range.
The Cambridge, UK-based company aims to recreate ‘upcycling’ in nature by feeding our food waste to fly larvae – which are then fed to livestock.
Alternative proteins have been touted as a solution to greening emissions-heavy food systems and have attracted billions in investment. But a new report warns they “will not save the planet.”
With Patrick Brown stepping aside, there are a few different directions the company could take in pursuit of profitability.
The Californian startup is helping to make seaweed “the most abundant, most sustainable” source of protein on Earth.
The Japanese startup is one of several companies that have discovered methods for removing animal serum from the cell culture process.
Jerky might seem like a strange choice, but it aligns with Beyond Meat’s mission to increase its retail sales in 2022.
The Coloradan startup claims its mycelium-based fermentation tech can enhance the flavor, functionality, and nutritional profile of plant-based meat analogs.
Brown, who founded the plant-based protein pioneer in 2011, will continue in the newly created role of ‘chief visionary officer’.
Lowercarbon Capital led the round.
Xi said that China “should shift our focus from farmland only” and use biotechnology to “obtain calories and protein from plants, animals, and microorganisms.”
Impossible says its patent on a beef substitute containing synthesized heme – which gives the effect of blood – is being infringed by Motif.
Helaina’s breastmilk alternative, made using precision fermentation, is a step up from formula and offers the same proteins found in human breastmilk.
The Mushroom Meat Co.’s CEO explains the ups and downs of starting (and growing) a clean-label protein company in today’s crowded industry.
The Swedish biotech company will take its mycelium-based protein ingredient from prototype stage to commercial-scale production by 2023.
Latin America and the Middle East also saw their respective shares of global alt-protein funding increase year-on-year.
The vaccine developed by Canadian company Medicago highlights the role plant-based proteins could play in speeding up response times to global health crises.
The firm has made the first close of its $15 million maiden fund, which it claims is the first to exclusively back Asia Pacific alt-protein startups.
But the startup needs to get regulatory approval before it can sell its cell-cultured salmon to US consumers.
Next Gen Foods has secured plant-based protein’s biggest Series A funding to date from investors including Temasek, GGV Capital, and Paul McCartney’s MPL Ventures.
Sponsored
International Fresh Produce Association launches year 3 of its produce accelerator